search
Back to results

Effectiveness of Improving Diagnostic and Communication Skills on Antibiotic Prescribing Appropriateness in Acute Cough (ISAAC-CAT)

Primary Purpose

Respiratory Tract Infections, Cough

Status
Unknown status
Phase
Not Applicable
Locations
Spain
Study Type
Interventional
Intervention
C-reactive protein rapid testing
Communication skill enhancement
Sponsored by
Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Respiratory Tract Infections focused on measuring Antimicrobial Stewardship, Cost-Benefit Analysis, Anti-Bacterial Agents, Primary Health Care

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • age equal or older than 18 years
  • first consultation for acute cough (new cough or worsening of a previous cough) as the predominant symptom
  • of up to 3 weeks' duration
  • which the clinician believes to be an infectious acute lower respiratory tract infection

Exclusion Criteria:

  • a working diagnosis of a non-infective disorder, such as heart failure, pulmonary embolus, oesophageal reflux, or allergy
  • use of antibiotics in the previous two weeks
  • immunological deficiencies, and/or
  • inability to provide informed consent or unable to follow the study procedures

Sites / Locations

  • La Marina Health Center

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm 4

Arm Type

Experimental

Experimental

Experimental

No Intervention

Arm Label

C-reactive protein rapid testing

Enhancement of communication skills

C-reactive protein + communication skills

Usual care

Arm Description

Continuous (workshop and monthly web-based training) disease-focused intervention with the use of C-reactive protein rapid testing.

Continuous (on-site and monthly online training) illness-focused intervention with enhancement of communication skills to optimise doctor-patient consultations and share decision making with the aid of patient-centred leaflets.

Continuous (workshop and monthly web-based training) disease-focused intervention with C-reactive protein rapid testing and on-site and continuous (monthly online training illness-focused intervention) with enhancement of communication skills to optimise doctor-patient consultations and share decision making with the aid of patient-centred leaflets.

Usual care.

Outcomes

Primary Outcome Measures

Antibiotic use
Number of antibiotics consumed (as documented in the CRFs and double-checked by the Pharmacy Unit of Institut Català de Salut that can track if the antibiotic has been dispensed at any of the Catalan pharmacies)
Health status
Quality of life score obtained using the EuroQol questionnaire

Secondary Outcome Measures

Re-consultations and complications
Number of re-consultation for new or worsening symptoms, new signs, or hospital admission, assessed by review of medical notes (practice staff, the local study team, or both using a standard form to report these data), and Number of complications regarding the ALRTI
Duration of symptoms and duration of severe symptoms
Number of days until symptoms are rated daily as 0 (no problem) (information is reported by patients in self-completed diaries)
Antibiotic prescription at the baseline visit
Number of antibiotic prescriptions at the baseline visit, differentiating immediate and delayed antibiotic prescribing, and antibiotic dispensing at the pharmacies
Drugs other than antibiotics
Number of non-antibiotic prescriptions (reported by patients in self-completed diaries)
Tests ordered by clinicians
Number of tests ordered by clinicians (reported in the CRF)
Patient satisfaction with care
Patient satisfaction score reported in the symptom diary. Measured with a question that has used in previous studies: How satisfied are you with the consultation? Range from 0 (nothing satisfied) to 5 (extremely satisfied).
Patient perception of the usefulness of the information received.
Patient perception score about the usefulness of the information received. Measured with a question that has used in previous studies: Do you consider that the information received from your doctor has been useful? Range from 0 (nothing useful) to 5 (extremely useful).
Patient future consulting intention
Patient future consulting intention score. Measured with a question that has used in previous studies: Do you think you will attend the doctor in future occasions in case you present the same symptoms? Range from 0 (totally unlikely) to 5 (sure).
Serious adverse events
Number of serious adverse events (assessed by review of medical notes (practice staff, the local study team, or both using a standard form to report these data)
Absenteeism
Number of days of sick leave (collected in the CRFs)

Full Information

First Posted
April 8, 2019
Last Updated
April 29, 2019
Sponsor
Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina
Collaborators
Universitat Internacional de Catalunya, Fundacio d'Atencio Primaria, Universitat Pompeu Fabra
search

1. Study Identification

Unique Protocol Identification Number
NCT03931577
Brief Title
Effectiveness of Improving Diagnostic and Communication Skills on Antibiotic Prescribing Appropriateness in Acute Cough
Acronym
ISAAC-CAT
Official Title
Effectiveness and Cost-effectiveness of Improving Clinicians' Diagnostic and Communication Skills on Antibiotic Prescribing Appropriateness in Patients With Acute Cough in Primary Care in Catalonia.
Study Type
Interventional

2. Study Status

Record Verification Date
April 2019
Overall Recruitment Status
Unknown status
Study Start Date
November 1, 2019 (Anticipated)
Primary Completion Date
February 28, 2021 (Anticipated)
Study Completion Date
December 31, 2021 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina
Collaborators
Universitat Internacional de Catalunya, Fundacio d'Atencio Primaria, Universitat Pompeu Fabra

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
Despite their marginal benefit, about 60% of uncomplicated acute lower respiratory infections (ALRTI) are currently treated with antibiotics. Several strategies have been developed to reduce inappropriate antibiotic prescribing, with the use of point-of-care C-reactive protein (CRP) testing and the improvement of the communication skills being the most effective interventions, but most of the studies have been carried out outside Mediterranean countries. This study is aimed at evaluating the effect of a disease-focused intervention (CRP) and an illness-focused intervention (improvement of communication skills to optimise doctor-patient consultations and share-decision making with the aid of patient-centred leaflets) on antibiotic prescribing for patients with ALRTIs in Catalan primary care by means of a cluster, randomised, factorial, controlled trial. Primary care centres will be assigned to four trial arms: usual care, use of CRP testing, enhanced communication skills backed up with leaflets, or combined interventions. The main outcome will be antibiotic use within the first 6 weeks and the quality adjusted life years. A pharmacoeconomic analysis of the impact of these interventions will be assessed.
Detailed Description
Background: Most antibiotics are prescribed in primary care, and most commonly for acute lower respiratory infections (ALRTI). Despite their marginal benefit, about 60% of these infections are currently treated with antibiotics in Catalonia, Spain. Several strategies have been developed to reduce inappropriate antibiotic prescribing, with the use of C-reactive protein (CRP) rapid testing and the improvement of the communication skills being the most effective interventions. However, most studies have been carried out outside Mediterranean countries. This study aims to evaluate the effectiveness and the efficiency of a continuous disease-focused intervention (CRP) and an illness-focused intervention (enhancement of communication skills to optimise doctor-patient consultations and share decision making with the aid of patient-centred leaflets) on antibiotic prescribing in patients with ALRTIs in Catalan primary care centres. Methods/design: A cluster, randomised, factorial, controlled trial aimed at including 20 primary care centres (n=2,940 patients) with patients older than 18 years presenting for a first consultation with ALRTI, therefore with presence of infected acute cough of up to 3 weeks' duration as the predominant symptom. Centres, according to socioeconomic and antibiotic consumption, will be randomly assigned according to hierarchical clustering to any of four trial arms: usual care, CRP testing, enhanced communication skills backed up with patient leaflets, or combined interventions. A cost-effectiveness and cost-utility analysis will be performed from the perspective of public health system. A qualitative study aimed at identifying the expectations and concerns in patients with ALRTIs and the satisfaction of clinicians with the different interventions will also be performed. Clinicians assigned to the interventions will participate in a 2-hour training workshop before the inception of the trial and will receive a monthly intervention-tailored training module during the trial. Clinical effectiveness will be measured by the antibiotic use within the first 6 weeks and the quality adjusted life years and secondary outcomes will be duration of illness and severity of cough measured with a symptom diary, healthcare reconsultations, hospital admissions and complications. National health care perspective will be adopted and the temporal horizon of the analysis will be one year. Health care costs will be considered and expressed in € of the current year of the analysis. Univariate and multivariate sensitivity analysis will be carried out. Discussion: The ISAAC-CAT project aims to improve the management of ALRTIs in primary care through use of two different clinicians' skills to help target antibiotic prescribing only to those most likely to benefit, and thereby reduce the risk of unnecessary exposure to antibiotics leading to adverse effects and/or the development of AMR without having a negative impact on health status, thus benefiting individual patients and society at large. This project will contribute to evaluate the effectiveness and efficiency of different strategies for more appropriate antibiotic prescribing that are currently out of the scope of the actual guidelines.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Respiratory Tract Infections, Cough
Keywords
Antimicrobial Stewardship, Cost-Benefit Analysis, Anti-Bacterial Agents, Primary Health Care

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Factorial Assignment
Model Description
Cluster randomised factorial controlled trial.
Masking
None (Open Label)
Allocation
Randomized
Enrollment
2940 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
C-reactive protein rapid testing
Arm Type
Experimental
Arm Description
Continuous (workshop and monthly web-based training) disease-focused intervention with the use of C-reactive protein rapid testing.
Arm Title
Enhancement of communication skills
Arm Type
Experimental
Arm Description
Continuous (on-site and monthly online training) illness-focused intervention with enhancement of communication skills to optimise doctor-patient consultations and share decision making with the aid of patient-centred leaflets.
Arm Title
C-reactive protein + communication skills
Arm Type
Experimental
Arm Description
Continuous (workshop and monthly web-based training) disease-focused intervention with C-reactive protein rapid testing and on-site and continuous (monthly online training illness-focused intervention) with enhancement of communication skills to optimise doctor-patient consultations and share decision making with the aid of patient-centred leaflets.
Arm Title
Usual care
Arm Type
No Intervention
Arm Description
Usual care.
Intervention Type
Diagnostic Test
Intervention Name(s)
C-reactive protein rapid testing
Other Intervention Name(s)
CRP
Intervention Description
Continuous (workshop and monthly web-based training) disease-focused intervention with the provision of CRP rapid testing in the primary care practices.
Intervention Type
Procedure
Intervention Name(s)
Communication skill enhancement
Other Intervention Name(s)
Leaflet provision
Intervention Description
Continuous (on-site and monthly online training) illness-focused intervention (enhancement of communication skills to optimise doctor-patient consultations and share decision making with the aid of patient-centred leaflets) in the primary care practices.
Primary Outcome Measure Information:
Title
Antibiotic use
Description
Number of antibiotics consumed (as documented in the CRFs and double-checked by the Pharmacy Unit of Institut Català de Salut that can track if the antibiotic has been dispensed at any of the Catalan pharmacies)
Time Frame
Day 42
Title
Health status
Description
Quality of life score obtained using the EuroQol questionnaire
Time Frame
Difference between baseline visit and day 42
Secondary Outcome Measure Information:
Title
Re-consultations and complications
Description
Number of re-consultation for new or worsening symptoms, new signs, or hospital admission, assessed by review of medical notes (practice staff, the local study team, or both using a standard form to report these data), and Number of complications regarding the ALRTI
Time Frame
Day 42
Title
Duration of symptoms and duration of severe symptoms
Description
Number of days until symptoms are rated daily as 0 (no problem) (information is reported by patients in self-completed diaries)
Time Frame
Day 42
Title
Antibiotic prescription at the baseline visit
Description
Number of antibiotic prescriptions at the baseline visit, differentiating immediate and delayed antibiotic prescribing, and antibiotic dispensing at the pharmacies
Time Frame
Baseline visit
Title
Drugs other than antibiotics
Description
Number of non-antibiotic prescriptions (reported by patients in self-completed diaries)
Time Frame
Day 42
Title
Tests ordered by clinicians
Description
Number of tests ordered by clinicians (reported in the CRF)
Time Frame
Day 42
Title
Patient satisfaction with care
Description
Patient satisfaction score reported in the symptom diary. Measured with a question that has used in previous studies: How satisfied are you with the consultation? Range from 0 (nothing satisfied) to 5 (extremely satisfied).
Time Frame
Day 14
Title
Patient perception of the usefulness of the information received.
Description
Patient perception score about the usefulness of the information received. Measured with a question that has used in previous studies: Do you consider that the information received from your doctor has been useful? Range from 0 (nothing useful) to 5 (extremely useful).
Time Frame
Day 14
Title
Patient future consulting intention
Description
Patient future consulting intention score. Measured with a question that has used in previous studies: Do you think you will attend the doctor in future occasions in case you present the same symptoms? Range from 0 (totally unlikely) to 5 (sure).
Time Frame
Day 14
Title
Serious adverse events
Description
Number of serious adverse events (assessed by review of medical notes (practice staff, the local study team, or both using a standard form to report these data)
Time Frame
Day 42
Title
Absenteeism
Description
Number of days of sick leave (collected in the CRFs)
Time Frame
Baseline visit

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: age equal or older than 18 years first consultation for acute cough (new cough or worsening of a previous cough) as the predominant symptom of up to 3 weeks' duration which the clinician believes to be an infectious acute lower respiratory tract infection Exclusion Criteria: a working diagnosis of a non-infective disorder, such as heart failure, pulmonary embolus, oesophageal reflux, or allergy use of antibiotics in the previous two weeks immunological deficiencies, and/or inability to provide informed consent or unable to follow the study procedures
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Ana Moragas, MD PhD
Phone
0034600072170
Ext
0034600072170
Email
anamaria.moragas@urv.cat
First Name & Middle Initial & Last Name or Official Title & Degree
Ana Garcia-Sangenis, MD
Phone
0034934824124
Ext
0034934824124
Email
agarcia@idiapjgol.org
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Rosa Morros, MD PhD
Organizational Affiliation
Clinical pharmacologist
Official's Role
Study Chair
Facility Information:
Facility Name
La Marina Health Center
City
Barcelona
State/Province
Catalonia
ZIP/Postal Code
08038
Country
Spain
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Josep M Cots, MD PhD
Phone
0034601381364
Ext
0034601381364
Email
23465jcy@comb.cat

12. IPD Sharing Statement

Plan to Share IPD
Yes
IPD Sharing Plan Description
Reposition in SCENTIA
IPD Sharing Time Frame
First 15 years after publication
IPD Sharing Access Criteria
On demand
IPD Sharing URL
http://scientiasalut.gencat.cat
Citations:
PubMed Identifier
33338078
Citation
Medina-Perucha L, Garcia-Sangenis A, Moragas A, Galvez-Hernandez P, Cots JM, Lanau-Roig A, Borras A, Amo I, Monfa R, Llor C, Berenguera A. Autonomy, power dynamics and antibiotic use in primary healthcare: A qualitative study. PLoS One. 2020 Dec 18;15(12):e0244432. doi: 10.1371/journal.pone.0244432. eCollection 2020.
Results Reference
derived
PubMed Identifier
31847912
Citation
Ruiz R, Moragas A, Trapero-Bertran M, Siso A, Berenguera A, Oliva G, Borras-Santos A, Garcia-Sangenis A, Puig-Junoy J, Cots JM, Morros R, Mora T, Lanau-Roig A, Monfa R, Troncoso A, Abellana RM, Galvez P, Medina-Perucha L, Bjerrum L, Amo I, Barragan N, Llor C. Effectiveness and cost-effectiveness of Improving clinicians' diagnostic and communication Skills on Antibiotic prescribing Appropriateness in patients with acute Cough in primary care in CATalonia (the ISAAC-CAT study): study protocol for a cluster randomised controlled trial. Trials. 2019 Dec 17;20(1):740. doi: 10.1186/s13063-019-3727-3.
Results Reference
derived

Learn more about this trial

Effectiveness of Improving Diagnostic and Communication Skills on Antibiotic Prescribing Appropriateness in Acute Cough

We'll reach out to this number within 24 hrs